NCT03761914 2024-11-19Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced CancersSellas Life Sciences GroupPhase 1/2 Completed26 enrolled 14 charts
NCT00616941 2022-10-12Phase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerLudwig Institute for Cancer ResearchPhase 1 Completed28 enrolled 16 charts